Table 2.
Summary of key published clinical studies examining the beneficial effects of the KD in neurological diseases.
Disease | Trial type | KD duration | Outcome | References |
---|---|---|---|---|
Alzheimer's disease | Randomized comparison of KD to high carbohydrate diet | 6 weeks | Improved verbal memory performance | (29) |
Single-arm | 12 weeks | Improved cognitive scores | (30) | |
Randomized crossover | 12 weeks | Improved quality of life, no improved memory | (31) | |
Dravet syndrome | Prospective study | 3-12 months | Reduced seizures and hyperactivity | (32) |
Epilepsy | Randomized, prospective and controlled | 3 months | Reduced seizure frequency | (11) |
Pharmacoresistant epileptic encephalopathy | Prospective study | 12 weeks | Improved cognitive function, reduced seizure frequency | (33) |
MS | Single-arm | 6 months | Significantly improved fatigue and depression scores | (34) |
Randomized three-armed parallel grouped, single center, controlled | 6 months | Improved quality of life and overall health | (35) | |
Parkinson's disease | Randomized, controlled, parallel-group trial | 8 weeks | Small increase in cognitive abilities but no change in motor function | (36) |